BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 130 filers reported holding BIOLIFE SOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,585,302 | -64.2% | 404,439 | -42.7% | 0.01% | -61.5% |
| Q2 2023 | $15,605,253 | -22.5% | 706,120 | -23.7% | 0.01% | -27.8% |
| Q1 2023 | $20,127,040 | +11.3% | 925,381 | -6.8% | 0.02% | 0.0% |
| Q4 2022 | $18,076,951 | +31.7% | 993,239 | +64.6% | 0.02% | +28.6% |
| Q3 2022 | $13,728,000 | +117.9% | 603,427 | +32.3% | 0.01% | +133.3% |
| Q2 2022 | $6,299,000 | -34.4% | 456,103 | +8.0% | 0.01% | -14.3% |
| Q1 2022 | $9,600,000 | -69.3% | 422,342 | -49.6% | 0.01% | -65.0% |
| Q4 2021 | $31,242,000 | +150.8% | 838,249 | +184.8% | 0.02% | +150.0% |
| Q3 2021 | $12,456,000 | -8.1% | 294,335 | -3.3% | 0.01% | -11.1% |
| Q2 2021 | $13,547,000 | +21.3% | 304,358 | -1.9% | 0.01% | +12.5% |
| Q1 2021 | $11,169,000 | -37.7% | 310,258 | -31.0% | 0.01% | -38.5% |
| Q4 2020 | $17,934,000 | – | 449,574 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,780,000 | $107,441,800 | 11.89% |
| Gagnon Advisors, LLC | 360,758 | $4,982,067 | 4.17% |
| Meros Investment Management, LP | 372,203 | $5,140,123 | 2.80% |
| Park West Asset Management LLC | 2,014,954 | $27,826,515 | 2.56% |
| GAGNON SECURITIES LLC | 633,363 | $8,746,743 | 2.19% |
| Mesirow Financial Investment Management, Inc. | 26,710 | $368,865 | 1.60% |
| Roubaix Capital, LLC | 146,898 | $2,028,661 | 1.50% |
| Millrace Asset Group, Inc. | 48,917 | $676 | 0.84% |
| Soleus Capital Management, L.P. | 439,000 | $6,062,590 | 0.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,363,638 | $18,831,841 | 0.53% |